Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Nancy Kamei Headshot

Nancy Kamei, PharmD, MBA

Program Director
SBIR Development Center
National Cancer Institute
nancy.kamei@nih.gov

Nancy Kamei is a program director in the National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center, where she oversees a portfolio of companies focused on cancer therapeutics.  Nancy is a serial entrepreneur having served on the start-up teams of four Silicon Valley biotechnology start-up companies (Onyx Pharmaceuticals) and has more than 20 years of experience as an investor, having selected and managed portfolios of both public equities (Capital Group Companies) and venture capital (Intel Capital). For several years prior to joining the government, she served as a national instructor for the I-CorpsTM Program, interacting with National Institutes of Health and National Science Foundation grantees.  She joined the NSF in 2017 as a Program Director where she served on the start-up team of the Convergence Accelerator and worked in the SBIR and I-Corps Programs.  After receiving her doctorate in pharmacy from the University of California, San Francisco, she started her career at Merck and then completed her master's degree in business administration at Stanford University’s Graduate School of Business.  Nancy also has over 40 years of service in the non-profit sector.

Email